ArticleScientific reports2025
Evaluation of dyslipidemia based on ATP III guideline in adults in Southwest Iran: a population-based study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of general obesity, metabolically healthy obesity, and abdominal adiposity markers with elevated liver enzymes: a population-based study.Scientific reports · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dyslipidemia is a primary risk factor for cardiovascular disease. This study aims to investigate the prevalence of dyslipidemia and its associated risk factors in the southwest region of Iran. This population-based cross-sectional study was conducted with 9846 participants aged 35 to 70 in southwest Iran. Data was collected on socioeconomic factors, demographic characteristics, comorbidities, laboratory tests, anthropometric measurements, and lifestyle variables. The criteria for dyslipidemia were based on the ATP III classification. A multivariable logistic regression model was used to control for potential confounders. Results showed that the overall prevalence of dyslipidemia was 43.5%, with abnormal levels of HDL, LDL, TC, and TG at 17.9, 21.8, 36.2, and 44%, respectively. The multivariable logistic regression analysis revealed that males (OR 1.92, 95% CI 1.74-2.14), individuals with abnormal waist circumference (OR 1.88, 95% CI 1.67-2.12), those with low physical activity (OR 1.30, 95% CI 1.15-1.46), smokers (OR 1.17, 95% CI 1.05-1.31), rich people (OR 1.19, 95% CI 1.04-1.36), and patients with hypertension (OR 1.16, 95% CI 1.05-1.27) had higher odds of dyslipidemia. Our findings suggest that dyslipidemia is a complex condition that is influenced by various biological and lifestyle factors. Different prevention and treatment strategies may be necessary for various population subgroups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.